Daily News Online

DateLine Friday, 1 February 2008

News Bar »

    News: Pakistan expresses gratitude for Lanka’s stance  ...            Political: Cabinet Committee to study APRC proposals ...           Business: Janashakthi Insurance to go for an IPO  ...            Sports: Will Sri Lanka upset Pakistan? ...

Home

 | SHARE MARKET  | EXCHANGE RATE  | TRADING  | PICTURE GALLERY  | ARCHIVES | 

dailynews
 ONLINE


OTHER PUBLICATIONS


OTHER LINKS

Marriage Proposals
Classified
Government Gazette

Business Health

BARAKA earns US $ one million per year

“BARAKA products earn over US $ one million worth of foreign exchange per year for Sri Lanka. There is a massive demand for herbal and natural products globally, though we the marketing is sluggish in our side. We expect this will increase in future,” CEO, Bio Extracts (Pvt) Ltd, Riza Bahardeen said.

He said, “Our value addition is more than hundred per cent for the seeds imported to manufacture BARAKA products. Black seeds are the vital and only raw material, imported to manufacture BARAKA products in Sri Lanka,”


BARAKA production line

“Some of our products ranged in BARAKA brand products are now registered in Australia, Malaysia, European Union, and South Africa. This gives a prestige to Sri Lanka, since the medicines are rarely registered under another country’s legislation. BARAKA products have obtained the approval from the formulation committee of Ayurvedic medicine, Department of Ayurveda,” he said.

“We are mainly an export oriented company, using the local herbs for our production except black seeds.

The raw materials used in our production are Gotukola, Karawila, Ekaveria, Karapincha, Cinnamon, Cardamom, Cloves and Citronella along with Black seeds to manufacture the total range of BARAKA products,” Bahardeen said.


CEO Riza Bahardeen

“We subject BARAKA products to toxicity tests, pharmacological studies and clinical trials before they are released to the market. The result of these researches has been published locally and internationally.

At present, there is a massive demand for herbal and natural medical and cosmetic products. The EU, USA, Middle-East and Asian markets demand these products on a huge way,” he said.

“BARAKA brands cater to high blood sugar, high cholesterol and hypertension, the range of oils, capsules, balms and creams, is reformed to suit the commercial demand for the ayurvedic medicine.

Now the western medical officers also encourage consuming herbal products, due to lack of side effects,” he further stated.


Sun Pharmaceuticals launches “Pantoprazole SDR Tab”

Drug Major Sun Pharmaceuticals has announced the commercial launch of generic Pantoprazole Sodium Delayed Release (DR) Tablets, 40 mg in the market. The drug is used for treating oesophagus ailments.

Sun Pharmaceuticals has launched the drug after the commercial launch by Teva Pharmaceutical Industries and Wyeth’s generic Pantoprazole Sodium tablets product.

This strength of Pantoprazole Sodium has annual sales of around 2.3 billion dollar in the US. The product is being sold by its marketing partner Caraco Pharmaceutical Laboratories.

The company had received a USFDA approval for these tablets in Sep 2007.

For the quarter to Dec 31, 2007, the company posted a net profit of Rs. 318.4 crore, compared with Rs. 199 crore for same period, corresponding year. During the same period, its net sales were up at Rs 803.9 crore versus Rs 540 crore.

The shares of the company reacted positively to the news and surged 9% to Rs. 1155 on the BSE, at the close of Wednesday’s trading. Stock Markets closed with huge loss on Wednesday as selling pressure continued in Blue-chip stocks.


Asia’s medical hub no second to Europe

Today, with Singapore, Asia’s medical hub, accounting for one-third of all JCI accredited facilities in Asia, Asians no longer have to seek greener pastures for healthcare services nor spend inexhaustible sums of money and time travelling to Europe.


KK Womens’ and Childrens’ Hospital, Singapore

A proven, reliable healthcare services hub; Singapore’s expertise is attracting a growing number of international patients, healthcare workers and related companies to headquarter, train and share their expertise, opening new vistas in the field of medical excellence in Asia.

Observations on the Singapore Public Health Services were hospital tours organised by the Singapore Tourism Board (STB) in collaboration with Singapore Health Services(SingHealth) focused on the hallmark of excellence in healthcare services, the levels of competence, quality, safety and reliability the country had to offer to Asia as a whole.

‘Today, we see an increasing flow of patients crossing boarders in search of better healthcare providers. The inexorable progress brings with it tremendous benefits as well as challenges, and perhaps even the need for some changes. While some call this medical tourism, I prefer the term ‘Medical travel ‘in order that this be put in proper perspective and not to be equated to just another ‘service industry’.

I would like to look at it from the view of ‘Medicine without Boarders’- Care before Business were the sentiments of Group CEO, Singapore Health Services (SGH), Prof. Tan Ser Kiat.

Director, Healthcare Services, Singapore Tourism Board, Dr. Jason C.H. Yap said in 2006 approximately 410,000 visitors out of the 9.7 million visitors to Singapore declared that their primary reason for coming to Singapore was for healthcare.

They brought about 86,000 accompanying persons, parents, caregivers, family members or friends. Singapore’s healthcare services are excellent.

Many South East Asian, Asian and world Firsts were developed and performed in Singapore. Singapore is geared to meet Asia’s Medical needs.’

Meanwhile, medical travel is more a part of the healthcare industry than the tourist industry.

The Singapore Tourism Board (STB) has the expertise to facilitate the inbound travel of patients and therefore takes charge of international branding and marketing and the development of associated people-oriented services like local Transport, accommodation and international patient liaison services. Singapore was voted the best Medical Travel Destination by Travel Weekly in 2007, an acknowledgement of STB’s work in international marketing.

The STB also encourages medical conferences in Singapore. The International Congress and Convention Association has ranked Singapore as the convention city in Asia and the second in the world for many years and more than a third of events held in Singapore are healthcare-related.


CIBA vision products here

CIBA vision, a world-leader in contact lenses and lens care products, has launched a select range of its contact lenses and lens care products to the Sri Lankan market, through their agents A. Baur and Company.

CIBA vision products, the world’s best selling cosmetic contact lenses with a range of products to suit the needs of different people, will be available in Sri Lanka, Professional Affairs Manager CIBA Vision - Singapore Adeline Chew said.

She said today’s women are forward in fashions and looking for fun and are ready to try new ways to express themselves.

CIBA Vision product range namely Freshlook, Dailies and Solo Care Focus, will be able to satisfy any market and fashion demand. According to Chew, their lenses are non-medicated medical cosmetic devices.

They have obtained patent rights for these eye - care products.

CIBA vision is the eye-care unit of Novatis AG, a world leader in health protection, disease curing and improving well-being, that operates in over 140 countries in the world. A Baur and company are the local distributor for their products.

 

EMAIL |   PRINTABLE VIEW | FEEDBACK

Gamin Gamata - Presidential Community & Welfare Service
Ceylinco Banyan Villas
www.srilankans.com
www.peaceinsrilanka.org
www.army.lk
www.news.lk
www.defence.lk
www.helpheroes.lk/

| News | Editorial | Business | Features | Political | Security | Sport | World | Letters | Obituaries |

Produced by Lake House Copyright © 2006 The Associated Newspapers of Ceylon Ltd.

Comments and suggestions to : Web Editor